$21.56
+0.69 (+3.31%)
Open$21.08
Previous Close$20.87
Day High$22.12
Day Low$20.74
52W High$34.39
52W Low$7.37
Volume—
Avg Volume4.85M
Market Cap3.62B
P/E Ratio—
EPS$-0.84
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+31.0% upside
Current
$21.56
$21.56
Target
$28.24
$28.24
$22.54
$28.24 avg
$42.65
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 90.21M | 66.38M | 421.41M |
| Net Income | -146,920,127 | -97,305,257 | -114,600,480 |
| Profit Margin | -162.9% | -154.7% | -27.2% |
| EBITDA | -157,637,602 | -110,203,636 | -127,773,532 |
| Free Cash Flow | — | — | -89,915,808 |
| Rev Growth | +35.9% | +35.9% | +7.1% |
| Debt/Equity | — | — | 0.61 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |